{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T03:21:30Z","timestamp":1788405690069,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Nuclear Cardiology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s12350-021-02608-8","type":"journal-article","created":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T13:03:08Z","timestamp":1618578188000},"page":"1919-1932","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Cardiac amyloidosis characterization by kinetic model fitting on [18F]florbetaben PET images"],"prefix":"10.1016","volume":"29","author":[{"given":"M.F.","family":"Santarelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Genovesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Scipioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Positano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Favilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Giorgetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Vergaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Landini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Emdin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Marzullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s12350-021-02608-8_bib1","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.pcad.2009.11.007","article-title":"Amyloid heart disease","volume":"52","author":"Falk","year":"2010","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1007\/s12350-021-02608-8_bib2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.pharmthera.2017.06.011","article-title":"Novel pharmacotherapies for cardiac amyloidosis","volume":"180","author":"Alexander","year":"2017","journal-title":"Pharmacol Ther"},{"key":"10.1007\/s12350-021-02608-8_bib3","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1161\/CIRCULATIONAHA.110.010447","article-title":"Cardiac amyloidosis: A treatable disease, often overlooked","volume":"124","author":"Falk","year":"2011","journal-title":"Circulation"},{"issue":"1","key":"10.1007\/s12350-021-02608-8_bib4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41572-018-0034-3","article-title":"Systemic immunoglobulin light chain amyloidosis","volume":"4","author":"Merlini","year":"2018","journal-title":"Nat Rev Dis Primers."},{"issue":"17","key":"10.1007\/s12350-021-02608-8_bib5","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.1182\/blood-2012-12-473066","article-title":"A European collaborative study of treatment outcomes in 346 patients with cardiac stage III AL amyloidosis","volume":"121","author":"Wechalekar","year":"2013","journal-title":"Blood"},{"issue":"38","key":"10.1007\/s12350-021-02608-8_bib6","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1093\/eurheartj\/ehv338","article-title":"Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction","volume":"36","author":"Gonz\u00e1lez-L\u00f3pez","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1007\/s12350-021-02608-8_bib7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.7326\/0003-4819-140-2-200401200-00008","article-title":"High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: An 8-year study","volume":"140","author":"Skinner","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1007\/s12350-021-02608-8_bib8","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1161\/CIRCULATIONAHA.111.078915","article-title":"Transthyretin (ATTR) cardiac amyloidosis","volume":"126","author":"Ruberg","year":"2012","journal-title":"Circulation"},{"key":"10.1007\/s12350-021-02608-8_bib9","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3816\/CLM.2005.n.048","article-title":"Amyloidosis: Diagnosis and management","volume":"6","author":"Gertz","year":"2005","journal-title":"Clin Lymph, Myel Leuk"},{"key":"10.1007\/s12350-021-02608-8_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4250\/jcvi.2019.27.e9","article-title":"Contemporary imaging diagnosis of cardiac amyloidosis","volume":"27","author":"Kim","year":"2019","journal-title":"J Cardiovasc Imaging"},{"issue":"1","key":"10.1007\/s12350-021-02608-8_bib11","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s12350-018-1365-x","article-title":"Cardiac amyloidosis imaging with amyloid positron emission tomography: A systematic review and meta-analysis","volume":"27","author":"Kim","year":"2020","journal-title":"J Nucl Cardiol."},{"issue":"7","key":"10.1007\/s12350-021-02608-8_bib12","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s00259-019-04290-y","article-title":"Detection of cardiac amyloidosis with 18 F-Florbetaben-PET\/CT in comparison to echocardiography, cardiac MRI and DPD-scintigraphy","volume":"46","author":"Kircher","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging."},{"issue":"1","key":"10.1007\/s12350-021-02608-8_bib13","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cpcardiol.2017.04.003","article-title":"Cardiac amyloidosis: An updated review with emphasis on diagnosis and future directions","volume":"43","author":"Bhogal","year":"2018","journal-title":"Curr Probl Cardiol"},{"key":"10.1007\/s12350-021-02608-8_bib14","article-title":"Cardiac amyloidosis detection by early bisphosphonate (99mTc-HMDP) scintigraphy","author":"Santarelli","year":"2020","journal-title":"J Nucl Cardiol"},{"issue":"6","key":"10.1007\/s12350-021-02608-8_bib15","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1007\/s12350-017-0856-5","article-title":"PET-CT evaluation of amyloid systemic involvement with [18F]-florbetaben in patient with proved cardiac amyloidosis: A case report","volume":"24","author":"Genovesi","year":"2017","journal-title":"J Nucl Cardiol."},{"key":"10.1007\/s12350-021-02608-8_bib16","article-title":"Imaging techniques as an aid in the early detection of cardiac amyloidosis","author":"Santarelli","year":"2020","journal-title":"Curr Pharm Des"},{"issue":"12","key":"10.1007\/s12350-021-02608-8_bib17","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1093\/ehjci\/jeu158","article-title":"The mosaic of the cardiac amyloidosis diagnosis: Role of imaging insubtypes and stages of the disease","volume":"15","author":"Di Bella","year":"2014","journal-title":"Eur Heart J Cardiovasc Imaging."},{"issue":"1","key":"10.1007\/s12350-021-02608-8_bib18","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12872-018-0952-8","article-title":"Diagnosis of cardiac amyloidosis: A systematic review on the role of imaging and biomarkers","volume":"18","author":"Kyriakou","year":"2018","journal-title":"BMC Cardiovasc Disord."},{"key":"10.1007\/s12350-021-02608-8_bib19","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s12350-017-0922-z","article-title":"Accuracy of 99mTc-hydroxymethylene diphosphonate scintigraphy for diagnosis of transthyretin cardiac amyloidosis","volume":"26","author":"Cappelli","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-021-02608-8_bib20","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1007\/s00259-018-4013-4","article-title":"Diagnostic accuracy of bone scintigraphy in the assessment of cardiac transthyretin-related amyloidosis: A bivariate meta-analysis","volume":"45","author":"Treglia","year":"2018","journal-title":"Eur J Nuclear Med Mol Imaging"},{"issue":"2","key":"10.1007\/s12350-021-02608-8_bib21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/CIRCIMAGING.112.000132","article-title":"99mTc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses","volume":"6","author":"Bokhari","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"issue":"11","key":"10.1007\/s12350-021-02608-8_bib22","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.2967\/jnumed.115.169870","article-title":"Cardiac amyloid imaging with 18F-florbetaben PET: A pilot study","volume":"57","author":"Law","year":"2016","journal-title":"J Nucl Med"},{"issue":"9","key":"10.1007\/s12350-021-02608-8_bib23","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1007\/s00259-014-2787-6","article-title":"Imaging cardiac amyloidosis: A pilot study using 18F-florbetapir positron emission tomography","volume":"41","author":"Dorbala","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-021-02608-8_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcvm.2015.00023","article-title":"A routine PET\/CT protocol with streamlined calculations for assessing cardiac amyloidosis using 18F-florbetapir","volume":"2","author":"Osborne","year":"2015","journal-title":"Frontiers Cardiovasc Med"},{"key":"10.1007\/s12350-021-02608-8_bib25","article-title":"Quantification of 11C-PIB kinetics in cardiac amyloidosis","author":"Kero","year":"2018","journal-title":"J Nucl Cardiol."},{"key":"10.1007\/s12350-021-02608-8_bib26","article-title":"[18F]-Florbetaben PET\/CT for differential diagnosis among cardiac immunoglobulin light chain, transthyretin amyloidosis, and mimicking conditions","author":"Genovesi","year":"2020","journal-title":"J Am Coll Cardiol Imaging"},{"key":"10.1007\/s12350-021-02608-8_bib27","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1111\/bjh.13156","article-title":"BCSH Committee. Guidelines on the diagnosis ad investigation of AL amyloidosis","volume":"168","author":"Gillmore","year":"2015","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1007\/s12350-021-02608-8_bib28","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.cpet.2007.08.003","article-title":"Tracer kinetic modeling in PET","volume":"2","author":"Bentourkia","year":"2007","journal-title":"PET Clin."},{"issue":"5","key":"10.1007\/s12350-021-02608-8_bib29","doi-asserted-by":"crossref","first-page":"723","DOI":"10.2967\/jnumed.112.107185","article-title":"PET quantification of 18F-florbetaben binding to amyloid deposits in human brains","volume":"54","author":"Becker","year":"2013","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-021-02608-8_bib30","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.compbiomed.2018.06.015","article-title":"Accelerated PET kinetic maps estimation by analytic fitting method","volume":"99","author":"Scipioni","year":"2018","journal-title":"Comput Biol Med"},{"key":"10.1007\/s12350-021-02608-8_bib31","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/00004647-200106000-00002","article-title":"Positron emission tomography compartmental models","volume":"21","author":"Gunn","year":"2001","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1007\/s12350-021-02608-8_bib32","series-title":"Model selection and multimodel inference: A practical information theoretic approach","first-page":"70","author":"Burnham","year":"2002"},{"key":"10.1007\/s12350-021-02608-8_bib33","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1214\/09-SS054","article-title":"A survey of cross-validation procedures for model selection","volume":"4","author":"Arlot","year":"2010","journal-title":"Stat. Surv."},{"issue":"1","key":"10.1007\/s12350-021-02608-8_bib34","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00259-014-2890-8","article-title":"Ethnic comparison of pharmacokinetics of 18F-florbetaben, a PET tracer for beta-amyloid imaging, in healthy Caucasian and Japanese subjects","volume":"42","author":"Senda","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-021-02608-8_bib35","article-title":"Cardiac amyloidosis: The starched heart","author":"Giorgetti","year":"2018","journal-title":"J Nucl Cardiol."},{"key":"10.1007\/s12350-021-02608-8_bib36","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretine amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"}],"container-title":["Journal of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-021-02608-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12350-021-02608-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123004543?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123004543?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-021-02608-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:11:20Z","timestamp":1761027080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071358123004543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S1071358123004543"],"URL":"https:\/\/doi.org\/10.1007\/s12350-021-02608-8","relation":{},"ISSN":["1071-3581"],"issn-type":[{"value":"1071-3581","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac amyloidosis characterization by kinetic model fitting on [18F]florbetaben PET images","name":"articletitle","label":"Article Title"},{"value":"Journal of Nuclear Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s12350-021-02608-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 American Society of Nuclear Cardiology. Published by ELSEVIER INC. All rights reserved. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}